Accelerate your path to successful clinical trials
Gain invaluable insights to optimize drug development with an adaptable digital platform that provides high-quality data about trials’ participants from Phase I to Phase III
![](https://beatsmedical.com/wp-content/uploads/2024/05/Clinical-trial.png)
Clinical trials encounter several challenges
![](https://beatsmedical.com/wp-content/uploads/2024/05/The-escalating-costs-of-drug-development-emphasize-the-importance-of-timely-decisions.png)
The escalating costs of drug development emphasize the importance of timely decisions
![](https://beatsmedical.com/wp-content/uploads/2024/05/Dropouts-and-slow-patient-recruitment-are-affecting-data-quality-and-trial-timelines.png)
Dropouts and slow patient recruitment are affecting data quality and trial timelines
![](https://beatsmedical.com/wp-content/uploads/2024/05/Embedded-digital-biomarkers-approach-1.png)
Traditional assessments lack the sensitivity needed to understand complex conditions
Clinical trials need a technology-based approach that use R&D data to inform rapid decision making
We support your trial participants by closely evaluating any progress in their condition and disease symptoms compared to baseline measurements. By integrating a digital platform into your clinical pipeline, digital objective assessments and ePROMs will be delivered remotely to measure safety, efficacy, and drug’s effectiveness compared to standard treatments or a placebo. Our cross-disease, multi-symptom platform technology, Colbolt©, requires no additional hardware and provides the broadest reach on the market across iOS and Android devices to capture high-quality data.
Integrate Colbolt© into your trials to gain the insights needed to advance your asset to market
![](https://beatsmedical.com/wp-content/uploads/2024/05/Discovery-1.png)
01 Discover how Colbolt© can support your drug trial
Simply translate your needs into a configurable digital platform that can be embedded from pre-clinical to commercialization
![](https://beatsmedical.com/wp-content/uploads/2024/05/10.png)
02 Deploy Colbolt© before recruiting patients
Configure and deploy Colbolt© to evaluate real world patient data that will shape current drug development activities
![](https://beatsmedical.com/wp-content/uploads/2024/05/11.png)
03 Recruit patients rapidly and collect continuous data
Recruit a robust pool of patients for the current trial, regardless of location, using smartphone sensors to capture high-quality objective data
![](https://beatsmedical.com/wp-content/uploads/2024/05/12.png)
04 Evaluate the datasets and publish meaningful results
Rapidly uncover insights through Colbolt© to obtain meaningful results and make decisions regarding your assets
![](https://beatsmedical.com/wp-content/uploads/2024/05/13.png)
05 Watch Colbolt© scale as your drug trial progresses to the next phase
Drug development doesn’t need to be so complex and expensive. Configure and deploy the Colbolt© platform to meet your goals across each trial phase, setting up for success before your asset reaches the market
Up to 40% reduction in costs related to managing logistics
70% patients retention over 12 months for high-quality data
5-fold increase in data precision to support your clinical trial
Cross-Disease Applicability with a Multi Symptom Focus
The Beats Medical Colbolt© platform can be deployed for a variety of CNS and rare conditions, targeting the most common symptoms with digital assessments that measure highly-engaged patients through their smartphones
![](https://beatsmedical.com/wp-content/uploads/2022/05/foot-1.png)
Mobility
![](https://beatsmedical.com/wp-content/uploads/2022/05/chat-1.png)
Speech
![](https://beatsmedical.com/wp-content/uploads/2022/05/tablet-1-1.png)
Dexterity
![](https://beatsmedical.com/wp-content/uploads/2022/05/brain-1.png)
QoL / ePROMs / Wellbeing
Trusted by
Integrate Colbolt© in your clinical trial
![](https://beatsmedical.com/wp-content/themes/beats-medical/dist/images/globe-image.png)
102%
increase in physical activityFacilitates impactful behavioural changes
5x
increase in data precisonGenerates more precise data than traditional assessments
97.9%
accuracyGreater sensitivity than any other solution in detecting mobility impairements
70%
retention ratePromotes high patient engagement and adherence over long periods